Utang jangka cendhak marang modal Biolase, Inc. (BIOL)

BIOLASE, Inc. (BIOL) generates revenue from the sale of dental lasers via a high-margin consumables model, utilizing automated lines for precision optical assembly. This chart illustrating the price evolution of the quotes on GURU.Markets shows the metric at 0.00. Patent protection and customer loyalty ensure stability within a niche segment, although limited demand constrains the brand's expansion rate.

Stable component supplies for BIOLASE dental lasers enable the optimization of working capital, while the short-term debt-to-equity ratio measures the proportion of short-term liabilities (over one year) within the capital structure, identifying risks of shareholder value dilution and assessing the balance between debt financing and financial stability to prevent liquidity gaps.